Chuikyo OKs Lagevrio, Voxzogo, Enjaymo, and More for August Listing, BioMarin Med with Biggest Peak Sales Outlook

MSD’s COVID-19 pills Lagevrio (molnupiravir) will newly join Japan’s NHI price list along with a throng of other drugs on August 18. BioMarin Pharmaceutical’s C-type natriuretic peptide Voxzogo (vosoritide) carries the largest peak sales forecast among all products on the...read more